These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
569 related articles for article (PubMed ID: 11059769)
1. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors. Oloumi A; MacPhail SH; Johnston PJ; Banáth JP; Olive PL Cancer Res; 2000 Oct; 60(20):5747-53. PubMed ID: 11059769 [TBL] [Abstract][Full Text] [Related]
2. Cell fusion studies to examine the mechanism for etoposide resistance in Chinese hamster V79 spheroids. Luo C; Johnston PJ; MacPhail SH; Banáth JP; Oloumi A; Olive PL Exp Cell Res; 1998 Sep; 243(2):282-9. PubMed ID: 9743588 [TBL] [Abstract][Full Text] [Related]
3. Identification of genes differentially expressed in V79 cells grown as multicell spheroids. Oloumi A; Lam W; Banáth JP; Olive PL Int J Radiat Biol; 2002 Jun; 78(6):483-92. PubMed ID: 12065053 [TBL] [Abstract][Full Text] [Related]
4. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth. Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604 [TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated human topoisomerase IIalpha gene transfer increases the sensitivity of etoposide-resistant human breast cancer cells. Zhou Z; Zwelling LA; Kawakami Y; An T; Kobayashi K; Herzog C; Kleinerman ES Cancer Res; 1999 Sep; 59(18):4618-24. PubMed ID: 10493516 [TBL] [Abstract][Full Text] [Related]
6. Topotecan-induced topoisomerase IIalpha expression increases the sensitivity of the CML cell line K562 to subsequent etoposide plus mitoxantrone treatment. Chen S; Gomez SP; McCarley D; Mainwaring MG Cancer Chemother Pharmacol; 2002 May; 49(5):347-55. PubMed ID: 11976828 [TBL] [Abstract][Full Text] [Related]
7. Transfection of 9-hydroxyellipticine-resistant Chinese hamster fibroblasts with human topoisomerase IIalpha cDNA: selective restoration of the sensitivity to DNA religation inhibitors. Khélifa T; René B; Le Mée S; Lambert B; Saucier JM; Markovits J; Jacquemin-Sablon H; Jacquemin-Sablon A Cancer Res; 1999 Oct; 59(19):4927-36. PubMed ID: 10519406 [TBL] [Abstract][Full Text] [Related]
8. Transfection of a human topoisomerase II alpha gene into etoposide-resistant human breast tumor cells sensitizes the cells to etoposide. Asano T; An T; Zwelling LA; Takano H; Fojo AT; Kleinerman ES Oncol Res; 1996; 8(3):101-10. PubMed ID: 8823806 [TBL] [Abstract][Full Text] [Related]
9. Induction of sensitivity to doxorubicin and etoposide by transfection of MCF-7 breast cancer cells with heregulin beta-2. Harris LN; Yang L; Tang C; Yang D; Lupu R Clin Cancer Res; 1998 Apr; 4(4):1005-12. PubMed ID: 9563896 [TBL] [Abstract][Full Text] [Related]
10. Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity. Errington F; Willmore E; Leontiou C; Tilby MJ; Austin CA Cancer Chemother Pharmacol; 2004 Feb; 53(2):155-62. PubMed ID: 14504921 [TBL] [Abstract][Full Text] [Related]
11. Topotecan increases topoisomerase IIalpha levels and sensitivity to treatment with etoposide in schedule-dependent process. Whitacre CM; Zborowska E; Gordon NH; Mackay W; Berger NA Cancer Res; 1997 Apr; 57(8):1425-8. PubMed ID: 9108439 [TBL] [Abstract][Full Text] [Related]
12. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines. Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249 [TBL] [Abstract][Full Text] [Related]
13. Interference with topoisomerase IIalpha potentiates melphalan cytotoxicity. Hirota H; Gosky D; Berger NA; Chatterjee S Int J Oncol; 2002 Feb; 20(2):311-8. PubMed ID: 11788894 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of topoisomerase IIalpha expression by transforming growth factor-beta1 is abrogated by the papillomavirus E7 protein. Satterwhite DJ; White RL; Matsunami N; Neufeld KL Cancer Res; 2000 Dec; 60(24):6989-94. PubMed ID: 11156401 [TBL] [Abstract][Full Text] [Related]
15. Decreased DNA topoisomerase II alpha expression and cold-sensitive growth in a mouse mammary cancer cell line resistant to etoposide and doxorubicin. Kawanami K; Nakamura T; Ono M; Kusano T; Okada K; Kikuchi A; Adachi N; Kohno K; Higashi K; Kuwano M Oncol Res; 1996; 8(5):197-206. PubMed ID: 8884812 [TBL] [Abstract][Full Text] [Related]
16. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses. Morgan SE; Cadena RS; Raimondi SC; Beck WT Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639 [TBL] [Abstract][Full Text] [Related]
17. Multicell spheroid response to drugs predicted with the comet assay. Olive PL; Banáth JP Cancer Res; 1997 Dec; 57(24):5528-33. PubMed ID: 9407963 [TBL] [Abstract][Full Text] [Related]
18. The cytochrome b5 tail anchors and stabilizes subdomains of human DNA topoisomerase II alpha in the cytoplasm of retrovirally infected mammalian cells. Soltermann A; Ernst A; Leroy D; Stahel RA; Gasser SM Exp Cell Res; 1999 Jun; 249(2):308-19. PubMed ID: 10366430 [TBL] [Abstract][Full Text] [Related]
19. DNA topoisomerase II expression, stability, and phosphorylation in two VM-26-resistant human leukemic CEM sublines. Chen M; Beck WT Oncol Res; 1995; 7(2):103-11. PubMed ID: 7579726 [TBL] [Abstract][Full Text] [Related]
20. Use of the comet assay to identify cells sensitive to tirapazamine in multicell spheroids and tumors in mice. Olive PL; Vikse CM; Banath JP Cancer Res; 1996 Oct; 56(19):4460-3. PubMed ID: 8813141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]